Perceptions and experiences with two no-test direct-to-patient telehealth medication abortion regimens in the USA: an exploratory study with mifepristone and misoprostol and misoprostol-only regimens
Introduction Telehealth medication abortion (teleMAB) is an option for expanding abortion access in the USA. In this study, we compared the accessibility of two no-test, direct-to-patient teleMAB regimens: mifepristone and misoprostol, and misoprostol-only.Research design and methods Over a 5-month...
Saved in:
Main Authors: | Dana Johnson (Author), Laura Fix (Author), Terri-Ann Thompson (Author), Melissa Grant (Author), Ibtehal Jastaniah (Author) |
---|---|
Format: | Book |
Published: |
BMJ Publishing Group,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of Mifepristone and Sublingual Misoprostol for Early Medical Abortion
by: Mau Lin, et al.
Published: (2006) -
Concurrent Use of Mifepristone and Misoprostol for Early Medical Abortion
by: Yiu-Tai Li, et al.
Published: (2006) -
Mifepristone and Misoprostol Induced Abortion with A Large Myomatous Uterus
by: Yiu-Tai Li, et al.
Published: (2005) -
Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol
by: Ellen R Wiebe, et al.
Published: (2020) -
Partial Hydatidiform Mole in a Medical Abortion with the Mifepristone/Misoprostol Combination
by: Pui-Ki Chow, et al.
Published: (2004)